{
  "report_rows": [
    {
      "kpi": "2Q26 total sales",
      "prediction": "BEAT",
      "answer": "pred ~$1.72B vs. cons $1.70B",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "2Q26 adjusted EPS",
      "prediction": "BEAT",
      "answer": "pred ~$0.77 vs. cons $0.74",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "2Q26 TAVR sales",
      "prediction": "IN-LINE",
      "answer": "pred ~$1.24B vs. cons $1.23B",
      "confidence": "MEDIUM"
    }
  ],
  "guide_rows": [
    {
      "kpi": "FY26 total-sales guidance midpoint",
      "prediction": "LOWER",
      "answer": "guide ~$6.70B vs. cons $6.73B (FY26)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "FY26 adjusted-EPS guidance midpoint",
      "prediction": "LOWER",
      "answer": "guide ~$3.00 vs. cons $3.02 (FY26)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "FY26 TAVR constant-currency growth guidance midpoint",
      "prediction": "LOWER",
      "answer": "guide ~8.0% vs. cons 8.5% (FY26)",
      "confidence": "MEDIUM"
    }
  ],
  "day1_residual_pct": -3.5,
  "day1_confidence": "MEDIUM",
  "day5_residual_pct": -5.5,
  "day5_path": "FOLLOW-THROUGH",
  "day5_rationale": "A ~$1.72B sales print and ~$0.77 EPS beat versus $1.70B and $0.74 consensus are likely outweighed by a ~$6.70B FY26 revenue midpoint versus $6.73B consensus and ~$3.00 EPS midpoint versus $3.02, implying modest out-period estimate cuts as tougher 2H TAVR comparisons remain the central concern.",
  "day5_confidence": "MEDIUM"
}